Indiva Ltd
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada. As of November 4, 2024, Indiva Limited operates as a subsidiary of SNDL In… Read more
Indiva Ltd (NDVAF) - Total Liabilities
Latest total liabilities as of March 2024: $39.10 Million USD
Based on the latest financial reports, Indiva Ltd (NDVAF) has total liabilities worth $39.10 Million USD as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Indiva Ltd - Total Liabilities Trend (2001–2023)
This chart illustrates how Indiva Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Indiva Ltd Competitors by Total Liabilities
The table below lists competitors of Indiva Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BluGlass Limited
PINK:BUGLF
|
USA | $8.11 Million |
|
EA Holdings Bhd
KLSE:0154
|
Malaysia | RM5.51 Million |
|
HLT Global Bhd
KLSE:0188
|
Malaysia | RM76.94 Million |
|
Bedding World Co., Ltd.
TWO:2938
|
Taiwan | NT$931.49 Million |
|
WestBond Enterprises Corporation
PINK:WBNEF
|
USA | $4.33 Million |
|
Sixty North Gold Mining Ltd
PINK:SXNTF
|
USA | $758.67K |
|
Winnergy Medical Public Company Limited
BK:WINMED
|
Thailand | ฿466.27 Million |
Liability Composition Analysis (2001–2023)
This chart breaks down Indiva Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -30.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indiva Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indiva Ltd (2001–2023)
The table below shows the annual total liabilities of Indiva Ltd from 2001 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $38.17 Million | +6.91% |
| 2022-12-31 | $35.70 Million | +18.56% |
| 2021-12-31 | $30.11 Million | +7.74% |
| 2020-12-31 | $27.95 Million | +48.55% |
| 2019-12-31 | $18.81 Million | +191.64% |
| 2018-12-31 | $6.45 Million | -26.09% |
| 2017-12-31 | $8.73 Million | +22.92% |
| 2017-10-31 | $7.10 Million | +290.00% |
| 2016-12-31 | $1.82 Million | +1120.42% |
| 2016-10-31 | $149.20K | +12.80% |
| 2015-12-31 | $132.26K | -14.17% |
| 2014-12-31 | $154.11K | +46.28% |
| 2013-12-31 | $105.35K | -35.99% |
| 2012-12-31 | $164.59K | -37.43% |
| 2011-12-31 | $263.04K | +1.76% |
| 2010-12-31 | $258.48K | -66.55% |
| 2009-12-31 | $772.75K | -3.07% |
| 2008-12-31 | $797.25K | -11.43% |
| 2007-12-31 | $900.15K | +28.04% |
| 2006-12-31 | $703.03K | +109.80% |
| 2005-12-31 | $335.10K | -55.52% |
| 2004-12-31 | $753.36K | +37.17% |
| 2003-12-31 | $549.20K | +55.52% |
| 2002-12-31 | $353.13K | -20.69% |
| 2001-12-31 | $445.25K | -- |